Cipla | CIPLA - Pre Tax Profit


Cipla reported INR7.49B in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Arca Biopharma USD -29.58M 694K Dec/2025
aTyr Pharma USD -153K 25.59M Mar/2026
Bio Path USD -976K 3.62M Sep/2025
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cara Therapeutics USD -4.91M 3.17M Mar/2025
Cipla INR 7.49B 4.2B Mar/2026
Dr.Reddys Laboratories INR 4.58B 11.09B Mar/2026
Immunic USD -19.3M 6.28M Dec/2025
Minerva Neurosciences USD 22.51M 30.74M Sep/2024
Nektar Therapeutics USD -34.7M 2.35M Dec/2025
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sun Pharmaceuticals INR 42.27B 595.5M Dec/2025
TherapeuticsMD USD -1.05M 241K Jun/2024
UPL INR 7.27B 850M Dec/2025